Renal Denervation Decreases Susceptibility to Arrhythmogenic Cardiac Alternans and Ventricular Arrhythmia in a Rat Model of Post-Myocardial Infarction Heart Failure

JACC. Basic to Translational Science
Sheng-Nan ChangChia-Ti Tsai

Abstract

Several studies have shown the beneficial effect of renal denervation (RDN) in the treatment of ventricular arrhythmia, especially in the setting of heart failure (HF). However, the underlying mechanism of antiarrhythmic effect of RDN is unknown. Arrhythmogenic cardiac alternans, particularly spatially discordant repolarization alternans, characterized by simultaneous prolongation and shortening of action potential duration (APD) in different myocardial regions, is central to the genesis of ventricular fibrillation in HF. Whether RDN decreases the susceptibility to arrhythmogenic cardiac alternans in HF has never been addressed before. The authors used a rat model of post-myocardial infarction HF and dual voltage-calcium optical mapping to investigate whether RDN could attenuate arrhythmogenic cardiac alternans that predisposes to ventricular arrhythmias, as well as the hemodynamic effect of RDN in HF. The HF rats had increased body weights, dilated hearts, and lower blood pressure. The HF rats also had longer ventricular APDs and a delay in the decay of the calcium transient, typical electrophysiological features of human HF. Susceptibility to calcium transient alternans, APD alternans, and spatially discordant APD alternans w...Continue Reading

References

Jun 6, 1998·Cardiovascular Research·S RichardJ Nargeot
Mar 17, 1999·Circulation·J M PastoreD S Rosenbaum
Jan 11, 2000·Circulation Research·J M Pastore, D S Rosenbaum
Feb 26, 2003·Circulation Research·Kenneth R LauritaMichael H Koo
Mar 16, 2004·Circulation Research·Etienne J PruvotKenneth R Laurita
Oct 16, 2004·Circulation Research·Gordon F Tomaselli, Douglas P Zipes
Jan 18, 2006·Journal of the American College of Cardiology·Sanjiv M Narayan
Jun 11, 2008·Cleveland Clinic Journal of Medicine·Douglas P Zipes
Feb 4, 2009·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Lance D WilsonDavid S Rosenbaum
Aug 28, 2009·The New England Journal of Medicine·Markus P SchlaichMurray D Esler
Oct 1, 2011·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Christian UkenaMichael Böhm
Feb 22, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Marmar VaseghiKalyanam Shivkumar
Jan 7, 2014·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Benjamin F RemoTimm Dickfeld

❮ Previous
Next ❯

Citations

May 19, 2019·International Journal of Molecular Sciences·Márcio Galindo KiuchiMarkus P Schlaich
Oct 20, 2020·Annual Review of Physiology·Thomas E Sharp, David J Lefer
Jun 29, 2021·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Yuichi HoriOlujimi A Ajijola

❮ Previous
Next ❯

Methods Mentioned

BETA
dissecting

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.